肥厚型心肌病被认为是一种常染色体显性遗传病,发病率约为1/200~1/500。临床表现以心室壁增厚为主要表现。超声心动图因其具有无创、快捷、实时的优点,被作为肥厚型心肌病的首选影像学检查方法之一。超声心动图多种新技术的开发与应用,...肥厚型心肌病被认为是一种常染色体显性遗传病,发病率约为1/200~1/500。临床表现以心室壁增厚为主要表现。超声心动图因其具有无创、快捷、实时的优点,被作为肥厚型心肌病的首选影像学检查方法之一。超声心动图多种新技术的开发与应用,尤其是多种新技术中提出的多种指标,对于超声科医生在临床工作中对肥厚型心肌病患者的诊断、心功能评估、预后评估、风险分层都有重要意义。Hypertrophic cardiomyopathy is considered to be an autosomal dominant genetic disease, with an incidence rate of about 1/200~1/500. The main clinical manifestation is ventricular wall thickening. Echocardiography is one of the preferred imaging methods for hypertrophic cardiomyopathy due to its non-invasive, fast, and real-time advantages. The development and application of various new technologies in echocardiography, especially the multiple indicators proposed in these technologies, are of great significance for ultrasound doctors in the clinical diagnosis, cardiac function assessment, prognosis evaluation, and risk stratification of patients with hypertrophic cardiomyopathy.展开更多
文摘肥厚型心肌病被认为是一种常染色体显性遗传病,发病率约为1/200~1/500。临床表现以心室壁增厚为主要表现。超声心动图因其具有无创、快捷、实时的优点,被作为肥厚型心肌病的首选影像学检查方法之一。超声心动图多种新技术的开发与应用,尤其是多种新技术中提出的多种指标,对于超声科医生在临床工作中对肥厚型心肌病患者的诊断、心功能评估、预后评估、风险分层都有重要意义。Hypertrophic cardiomyopathy is considered to be an autosomal dominant genetic disease, with an incidence rate of about 1/200~1/500. The main clinical manifestation is ventricular wall thickening. Echocardiography is one of the preferred imaging methods for hypertrophic cardiomyopathy due to its non-invasive, fast, and real-time advantages. The development and application of various new technologies in echocardiography, especially the multiple indicators proposed in these technologies, are of great significance for ultrasound doctors in the clinical diagnosis, cardiac function assessment, prognosis evaluation, and risk stratification of patients with hypertrophic cardiomyopathy.
